Evidence map›Paper›PMID 33204725›Full record

ArticleBioMed research international2020

Identifying the Potential Causes, Consequences, and Prevention of Communicable Diseases (Including COVID-19).

Muhammad Khalid Anser, Talat Islam, Muhammad Azhar Khan, Khalid Zaman, Abdelmohsen A Nassani, Sameh E Askar, Muhammad Moinuddin Qazi Abro, Ahmad Kabbani

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Does COVID-19 pandemic disrupt sustainable supply chain process? Covering some new global facts.Environmental science and pollution research international · 2021
    Article
  3. Socio-economic and corporate factors and COVID-19 pandemic: a wake-up call.Environmental science and pollution research international · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 5 countries.

Muhammad Khalid AnserSchool of Public Administration, Xi'an University of Architecture and Technology, Xi'an, China.ORCID https://orcid.org/0000-0003-1882-0907
Talat IslamInstitute of Business Administration, University of the Punjab, Quaid-i-Azam Campus, Lahore, Pakistan.ORCID https://orcid.org/0000-0002-3968-4513
Muhammad Azhar KhanDepartment of Economics, University of Haripur, Khyber Pakhtunkhwa, Haripur, Pakistan.ORCID https://orcid.org/0000-0003-2981-350X
Khalid ZamanDepartment of Economics, University of Haripur, Khyber Pakhtunkhwa, Haripur, Pakistan.ORCID https://orcid.org/0000-0002-2585-2790
Abdelmohsen A NassaniDepartment of Management, College of Business Administration, King Saud University, P.O. Box 71115, Riyadh 11587, Saudi Arabia.ORCID https://orcid.org/0000-0001-9658-8299
Sameh E AskarDepartment of Statistics and Operations Research, College of Science, King Saud University, P.O. Box 11451, Riyadh 11587, Saudi Arabia.ORCID https://orcid.org/0000-0001-9884-5930
Muhammad Moinuddin Qazi AbroDepartment of Management, College of Business Administration, King Saud University, P.O. Box 71115, Riyadh 11587, Saudi Arabia.ORCID https://orcid.org/0000-0003-1343-0395
Ahmad KabbaniDepartment of Management, Aleppo University, Aleppo, Syria.ORCID https://orcid.org/0000-0002-3479-3438
King Saud University · SAUniversity of Haripur · PKUniversity of Aleppo · SYUniversity of the Punjab · PKXi'an University of Architecture and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Communicable and noncommunicable diseases cause millions of deaths every year, increased billions of healthcare expenditures, and consequently increase trillions of economic losses at a global scale. This study more focused on the prevalence of communicable diseases, including COVID-19 that is an emerging pandemic, which affects the global economy. The objective of the study is to examine the impact of population density, lack of sanitation facilities, chemical concentration, fossil fuel combustions, poverty incidence, and healthcare expenditures on communicable diseases including COVID-19. The study covered a large panel of heterogenous countries to assess the relationships between the stated factors by using the robust least square regression, Granger causality test, and innovation accounting matrix. The study used a time series data from 2010 to 2019 for assessing the determinants of communicable diseases, while it is further extended with the current data of 2019-2020 for the COVID-19 pandemic. The results of the study show that high population density, lack of primary handwashing facilities, chemicals used in manufacturing value-added fossil fuel combustion, and poverty headcount substantially increase communicable diseases. In contrast, population diffusion, low carbon concentration in air, renewable fuels, and healthcare expenditures decrease infectious diseases in a panel of 78 countries. The causal inferences found the bidirectional relationship between communicable diseases and primary handwashing facility, and carbon emissions and poverty headcount, whereas the unidirectional relationship is running from lack of sanitation to infectious diseases, economic growth to carbon emissions, and communicable diseases to fossil fuel combustion across countries. Communicable diseases increase healthcare expenditures and decrease the country's economic growth which is a vital concern of the global economy to confront the outbreak of novel coronavirus through increasing the healthcare budget in national bills and stabilize financial activities at a worldwide scale.

Indexed as

Communicable Disease ControlCommunicable DiseasesCOVID-19Fossil FuelsHealth ExpendituresHumansPopulation DensityPovertySanitationSARS-CoV-2Fossil Fuels

Identifiers

PMID33204725
PMCPMC7643374
OpenAlexW3095627771

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.